These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 21208174)

  • 21. MRI manifestation of novel superparamagnetic iron oxide nanoparticles in the rat inner ear.
    Zou J; Zhang W; Poe D; Qin J; Fornara A; Zhang Y; Ramadan UA; Muhammed M; Pyykkö I
    Nanomedicine (Lond); 2010 Jul; 5(5):739-54. PubMed ID: 20662645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration.
    Cai H; Wen X; Wen L; Tirelli N; Zhang X; Zhang Y; Su H; Yang F; Chen G
    Int J Nanomedicine; 2014; 9():5591-601. PubMed ID: 25489245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities.
    Mittal R; Pena SA; Zhu A; Eshraghi N; Fesharaki A; Horesh EJ; Mittal J; Eshraghi AA
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1312-1320. PubMed ID: 30987439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anatomical basis of drug delivery to the inner ear.
    Glueckert R; Johnson Chacko L; Rask-Andersen H; Liu W; Handschuh S; Schrott-Fischer A
    Hear Res; 2018 Oct; 368():10-27. PubMed ID: 30442227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ear Cubes for local controlled drug delivery to the inner ear.
    Gehrke M; Sircoglou J; Gnansia D; Tourrel G; Willart JF; Danede F; Lacante E; Vincent C; Siepmann F; Siepmann J
    Int J Pharm; 2016 Jul; 509(1-2):85-94. PubMed ID: 27050866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized phospholipid-based nanoparticles for inner ear drug delivery and therapy.
    Yang KJ; Son J; Jung SY; Yi G; Yoo J; Kim DK; Koo H
    Biomaterials; 2018 Jul; 171():133-143. PubMed ID: 29689410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A state-of-the-art analysis of pharmacological delivery and artificial intelligence techniques for inner ear disease treatment.
    Li W; Zheng N; Zhou Q; Alqahtani MS; Elkamchouchi DH; Zhao H; Lin S
    Environ Res; 2023 Nov; 236(Pt 1):116457. PubMed ID: 37459944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomedicine for Inner Ear Diseases: A Review of Recent
    Kim DK
    Biomed Res Int; 2017; 2017():3098230. PubMed ID: 29130038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
    Weber S; Zimmer A; Pardeike J
    Eur J Pharm Biopharm; 2014 Jan; 86(1):7-22. PubMed ID: 24007657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner ear.
    Yoon JY; Yang KJ; Kim DE; Lee KY; Park SN; Kim DK; Kim JD
    Biomaterials; 2015 Dec; 73():243-53. PubMed ID: 26414408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outlook and future of inner ear therapy.
    Devare J; Gubbels S; Raphael Y
    Hear Res; 2018 Oct; 368():127-135. PubMed ID: 29804723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trials for inner ear drugs: Design and execution challenges.
    Jung DH; Rauch SD
    Hear Res; 2018 Oct; 368():123-126. PubMed ID: 29602591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015).
    Nguyen K; Kempfle JS; Jung DH; McKenna CE
    Expert Opin Ther Pat; 2017 Feb; 27(2):191-202. PubMed ID: 27855527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of nanoparticle drug-delivery systems for the inner ear.
    An X; Zha D
    Nanomedicine (Lond); 2020 Aug; 15(20):1981-1993. PubMed ID: 32605499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intracochlear drug delivery in combination with cochlear implants : Current aspects].
    Plontke SK; Götze G; Rahne T; Liebau A
    HNO; 2016 Nov; 64(11):797-807. PubMed ID: 27757480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soft- and hard-lipid nanoparticles: a novel approach to lymphatic drug delivery.
    Jeong SH; Jang JH; Cho HY; Lee YB
    Arch Pharm Res; 2018 Aug; 41(8):797-814. PubMed ID: 30074202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomedicine strategy for optimizing delivery to outer hair cells by surface-modified poly(lactic/glycolic acid) nanoparticles with hydrophilic molecules.
    Wen X; Ding S; Cai H; Wang J; Wen L; Yang F; Chen G
    Int J Nanomedicine; 2016; 11():5959-5969. PubMed ID: 27877041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inner ear drug delivery using liposomes.
    Mohammadian F; Eatemadi A; Daraee H
    Cell Mol Biol (Noisy-le-grand); 2017 Jan; 63(1):28-33. PubMed ID: 28234628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible opening of the blood-labyrinth barrier by low-pressure pulsed ultrasound and microbubbles for the treatment of inner ear diseases.
    He Y; Chen Z; Liu Q; Li Z; Wen D; Zhang H; Zhang M; Jiang D; Li H; Wen L; Chen G
    J Control Release; 2024 Aug; 372():318-330. PubMed ID: 38906419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticle-based delivery system for application of siRNA in vivo.
    Wang Y; Li Z; Han Y; Liang LH; Ji A
    Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.